Surveillance of Antimicrobial Resistance among Clinical Isolates from Surgery Wards in Peking Union Medical College Hospital
-
摘要:
目的 了解北京协和医院外科住院患者临床分离细菌分布及对抗菌药物的耐药性。 方法 收集2012年1月1日至2013年12月31日北京协和医院外科住院患者临床分离的3084株非重复细菌, 采用纸片扩散法或自动化仪器法进行药敏试验, 按美国临床实验室标准化协会2013年版标准判读药敏结果, 采用WHONET 5.6软件进行数据分析。 结果 3084株非重复细菌中, 10种最常见的细菌依次为鲍曼不动杆菌(14.1%)、大肠埃希菌(12.4%)、铜绿假单胞菌(12.4%)、肺炎克雷伯菌(11.8%)、金黄色葡萄球菌(8.9%)、粪肠球菌(5.4%)、凝固酶阴性葡萄球菌(5.3%)、阴沟肠杆菌(3.7%)、嗜麦芽窄食单胞菌(3.6%)和屎肠球菌(3.2%), 其中革兰阴性菌占71.6%(2208株), 革兰阳性菌占28.4%(876株)。耐甲氧西林金黄色葡萄球菌(methicillin-resistant Staphylococcus aureus, MRSA)和耐甲氧西林凝固酶阴性葡萄球菌(methicillin-resistant coagulase-negative Staphylococcus, MRCNS)的检出率分别为42.7%(117/274)和77.3%(119/154)。MRSA和MRCNS对β-内酰胺类和其他抗菌药物的耐药率明显高于甲氧西林敏感金黄色葡萄球菌(methicillin-susceptible Staphylococcus aureus, MSSA)和甲氧西林敏感凝固酶阴性葡萄球菌(methicillin-susceptible coagulase-negative Staphylococcus, MSCNS)。MRSA中80.3%菌株对磺胺甲噁唑-甲氧苄啶敏感, MRCNS中95.0%菌株对利福平敏感。未发现对万古霉素、替考拉宁和利奈唑胺耐药的葡萄球菌。粪肠球菌对大多数抗菌药物的耐药率明显低于屎肠球菌, 但后者对氯霉素的耐药率较低, 仅为4.3%。分别发现1株和5株万古霉素耐药的粪肠球菌和屎肠球菌。未发现对利奈唑胺耐药的肠球菌。产超广谱β-内酰胺酶(extended spectrum β-lactamases, ESBLs)的大肠埃希菌、克雷伯菌属细菌(肺炎克雷伯菌和产酸克雷伯菌)和奇异变形杆菌的检出率分别为56.7%(217/383)、23.8%(97/408)和22.8%(13/57)。产ESBLs菌株的耐药率明显高于非产ESBLs菌株。肠杆菌科细菌对碳青霉烯类抗菌药物仍高度敏感, 总耐药率1.6%~3.3%。泛耐药肺炎克雷伯菌的检出率为0.8%(3/363)。铜绿假单胞菌对亚胺培南和美罗培南的耐药率分别为19.5%和15.0%, 对阿米卡星的耐药率最低(8.6%); 鲍曼不动杆菌对上述两种抗菌药物的耐药率分别为74.1%和74.0%, 对米诺环素和头孢哌酮-舒巴坦的耐药率最低(28.9%和51.5%)。泛耐药鲍曼不动杆菌和铜绿假单胞菌的检出率分别为44.3%(193/436)和0.8%(3/381)。 结论 定期进行耐药性监测有助于了解细菌耐药性变迁, 为临床经验用药提供依据。 Abstract:Objective To investigate the distribution and antimicrobial resistance of clinical isolates from surgery wards in Peking Union Medical College Hospital (PUMCH). Methods A total of 3084 non-duplicate clinical isolates were collected from PUMCH surgery wards during the period from January 1, 2012 to December 31, 2013. Disc diffusion test (Kirby-Bauer method) and automated systems were employed to detect the antimicrobial resistance of these isolates. The data were analyzed by WHONET 5.6 software according to Clinical and Laboratory Standards Institute 2013 breakpoints. Results Of the 3084 clinical isolates, the 10 most common bacteria isolated were:A.baumannii(14.1%), E.coli (12.4%), P.aeruginosa(12.4%), K.pneumonia(11.8%), S.aureus(8.9%), E.faecalis(5.4%), coagulase-negative staphylococcus(5.3%), E.cloacae(3.7%), S.maltophilia(3.6%) and E.faecium(3.2%), in which gram-negative bacteria accounted for 71.6% (2208 isolates) and gram-positive accounted for 28.4% (876 isolates). In S.aureus and coagulase-negative staphylococcus, methicillin-resistant strains (MRSA and MRCNS) accounted for 42.7% (117/274) and 77.3% (119/154), respectively. The resistance rates of methicillin-resistance strains to β-lactams and other antimicrobial agents were much higher than those of methicillin-susceptive strains including methicillin-susceptible Staphylococcus aureus(MSSA) and methicillin-susceptible coagulase-negative Staphylococcus(MSCNS). In addition, 80.3% of MRSA strains were still susceptible to trimethoprim-sulfamethoxazole, while 95.0% of MRCNS strains were susceptible to rifampin. No staphylococcal strains were found resistant to vancomycin, teicoplanin, or linezolid. The drug resistance rates of E.faecalis strains to most antimicrobials tested were much lower than those of E.faecium, except for the resistance rate to chloramphenicol, which was only 4.3% in E.faecium. One strain of E.faecalis and 5 strains of E.faecium were found resistant to vancomycin. No linezolid-resistant strains were found in enterococcal isolates. Extended spectrum β-lactamases (ESBLs)-producing strains accounted for 56.7% (217/383), 23.8% (97/408), and 22.8% (13/57) in E.coli, Klebsiella species(K.pneumoniae and K.oxytoca), and P.mirabilis, respectively. The drug resistance rates of ESBLs-producing strains were higher than the corresponding non-ESBLs-producing strains. Enterobacteriaceae strains were still highly susceptible to carbapenems, the overall resistance rates being 1.6%-3.3%. A few pan-resistant strains of K. pneumoniae(0.8%, 3/363)were identified. The resistance rates of P.aeruginosa to imipenem and meropenem were 19.5% and 15.0%, respectively, while the resistance rate to amikacin was the lowest (8.6%). The resistance rates of A.baumannii to imipenem and meropenem were 74.1% and 74.0%, respectively, compared with the lowest resistance rates to cefoperazone-sulbactam (51.5%) and minocycline (28.9%). The prevalence of pan-resistant strains in A.baumannii and P.aeruginosa were 44.3% (193/436) and 0.8% (3/381), respectively. Conclusion Regular surveillance of bacterial resistance could provide practical guidance of rational selection of antimicrobial agents for clinicians. -
表 1 2012—2013年北京协和医院外科病房菌种分布
菌种 菌株数 构成比(%) 革兰阴性菌 鲍曼不动杆菌 436 19.7 大肠埃希菌 383 17.4 铜绿假单胞菌 381 17.3 肺炎克雷伯菌 363 16.4 阴沟肠杆菌 115 5.2 嗜麦芽窄食单胞菌 111 5.0 奇异变形杆菌 57 2.6 产气肠杆菌 48 2.2 黏质沙雷菌 48 2.2 产酸克雷伯菌 45 2.0 流感嗜血杆菌 29 1.3 其他 192 8.7 总计 2208 100 革兰阳性菌 金黄色葡萄球菌 274 31.3 粪肠球菌 166 18.9 凝固酶阴性葡萄球菌* 154 17.6 屎肠球菌 99 11.3 鹑鸡肠球菌 24 2.7 肺炎链球菌 21 2.4 草绿色链球菌* 20 2.3 B群链球菌 12 1.4 其他 106 12.1 总计 876 100 *仅从血液和其他无菌体液分离 表 2 2012—2013年北京协和医院外科病房分离的葡萄球菌属对抗菌药物的耐药率和敏感率(%)
抗菌药物 MSSA(157株) MRSA(117株) MSCNS(35株) MRCNS(119株) 耐药率 敏感率 耐药率 敏感率 耐药率 敏感率 耐药率 敏感率 青霉素 83.9 16.1 100 0 71.4 28.6 100 0 苯唑西林 0 100 100 0 0 100 100 0 头孢西丁 0 100 100 0 0 100 100 0 庆大霉素 30.1 69.9 71.8 28.2 5.4 91.9 44.6 52.1 环丙沙星 13.5 85.0 79.8 20.2 17.4 82.6 61.1 37.9 红霉素 59.0 37.8 86.3 11.1 62.2 29.7 90.9 7.4 万古霉素 0 100 0 100 0 100 0 100 利奈唑胺 0 100 0 100 0 100 0 100 替考拉宁 0 100 0 100 0 100 0 100 磺胺甲噁唑-甲氧苄啶 32.7 66.7 19.7 80.3 25.0 72.2 63.3 34.2 克林霉素 34.0 64.1 68.4 29.1 16.2 81.1 35.8 60.0 利福平 1.9 98.1 53.8 46.2 2.7 97.3 5.0 95.0 MSSA:甲氧西林敏感金黄色葡萄球菌;MRSA:耐甲氧西林金黄色葡萄球菌;MSCNS:甲氧西林敏感凝固酶阴性葡萄球菌;MRCNS:耐甲氧西林凝固酶阴性葡萄球菌 表 3 2012—2013年北京协和医院外科病房分离的粪肠球菌和屎肠球菌对抗菌药物的耐药率和敏感率(%)
抗菌药物 粪肠球菌(166株) 屎肠球菌(99株) 耐药率 敏感率 耐药率 敏感率 氨苄西林 11.5 88.5 89.1 10.9 高浓度庆大霉素 25.0 66.7 52.7 45.1 环丙沙星 31.9 46.9 87.6 6.2 红霉素 64.1 13.1 85.4 2.1 万古霉素 0.6 99.4 5.1 90.3 利奈唑胺 0 100 0 100 替考拉宁 0 100 3.0 97.0 氯霉素 23.4 70.8 4.3 78.5 四环素 76.9 23.1 54.6 44.3 利福平 52.6 22.1 88.4 7.4 磷霉素* 2.4 97.6 *仅从尿液标本分离 表 4 2012—2013年北京协和医院外科病房分离的大肠埃希菌和克雷伯菌属对抗菌药物的耐药率和敏感率(%)
抗菌药物 大肠埃希菌 克雷伯菌属 ESBLs(+)(217株) ESBLs(-)(166株) ESBLs(+)(97株) ESBLs(-)(311株) 耐药率 敏感率 耐药率 敏感率 耐药率 敏感率 耐药率 敏感率 哌拉西林 98.1 0.9 32.7 44.9 98.9 1.1 13.6 81.1 氨苄西林-舒巴坦 44.2 27.6 16.8 68.3 70.5 12.6 11.8 81.4 哌拉西林-他唑巴坦 9.7 84.3 4.4 93.0 13.4 57.7 4.7 92.7 头孢哌酮-舒巴坦 12.1 66.5 3.8 94.3 16.0 51.1 5.6 92.4 头孢呋辛 99.5 0.5 16.9 77.0 94.7 1.1 13.6 82.9 亚胺培南 0.9 99.1 0 10.0 1.0 99.0 0 100 美罗培南 0.9 99.1 0 100 1.0 99.0 0 100 厄他培南 2.0 95.1 0.7 99.3 3.4 89.8 5.0 94.3 头孢他啶 38.8 43.5 5.6 93.2 53.6 35.1 7.2 92.1 头孢噻肟 99.5 0.5 13.2 85.5 94.8 4.2 9.2 88.5 头孢吡肟 31.3 48.4 1.9 95.0 16.7 59.4 5.6 92.4 氨曲南 64.8 24.5 7.0 90.4 67.7 24.0 6.2 92.8 庆大霉素 59.5 39.5 36.9 63.1 52.6 47.4 7.0 93.0 阿米卡星 9.7 86.6 1.3 94.3 13.5 83.3 3.0 96.4 环丙沙星 80.1 18.5 55.9 43.5 57.9 30.5 8.8 86.3 磺胺甲噁唑-甲氧苄啶 71.2 27.0 47.1 51.0 75.5 23.4 14.8 82.6 米诺环素 24.1 63.9 17.7 71.0 36.2 32.5 8.8 80.9 ESBLs:产超广谱β-内酰胺酶 表 5 2012—2013年北京协和医院外科病房分离的肠杆菌科细菌对抗菌药物的耐药率和敏感率(%)
抗菌药物 阴沟肠杆菌(115株) 奇异变形杆菌(57株) 黏质沙雷菌(48株) 产气肠杆菌(48株) 耐药率 敏感率 耐药率 敏感率 耐药率 敏感率 耐药率 敏感率 哌拉西林 31.2 67.9 23.2 73.2 17.4 80.4 20.8 70.8 氨苄西林-舒巴坦 62.8 24.8 17.5 77.2 85.1 4.3 43.8 43.8 哌拉西林-他唑巴坦 13.3 77.0 0 100 6.4 89.4 8.3 75.0 头孢哌酮-舒巴坦 8.3 78.0 1.8 96.5 8.7 89.1 4.3 87.0 头孢呋辛 60.0 29.1 27.3 72.7 100 0 53.3 35.6 亚胺培南 1.8 98.2 0 100 2.3 97.7 0 100 美罗培南 1.8 98.2 0 100 2.2 97.8 0 100 厄他培南 11.1 75.0 0 100 4.7 90.7 4.5 86.4 头孢他啶 25.7 69.9 5.3 93.0 4.3 93.6 18.8 77.1 头孢噻肟 34.8 55.4 26.8 73.2 17.4 71.7 27.1 70.8 头孢吡肟 3.5 94.7 1.8 93.0 8.7 91.3 0 97.9 氨曲南 27.7 71.4 3.5 96.5 8.5 87.2 14.9 78.7 庆大霉素 11.8 85.5 28.6 62.5 10.6 87.2 8.5 91.5 阿米卡星 3.6 92.0 1.8 98.2 4.3 95.7 0 100 环丙沙星 13.3 83.2 42.1 50.9 8.5 89.4 4.3 89.4 磺胺甲噁唑-甲氧苄啶 20.9 78.2 57.1 41.1 2.1 95.7 14.6 85.4 米诺环素 14.4 67.8 81.8 2.3 7.7 79.5 13.9 77.8 表 6 2012—2013年北京协和医院外科病房分离的非发酵糖菌对抗菌药物的耐药率和敏感率(%)
抗菌药物 鲍曼不动杆菌(436株) 铜绿假单胞菌(381株) 嗜麦芽窄食单胞菌(111株) 耐药率 敏感率 耐药率 敏感率 耐药率 敏感率 氨苄西林-舒巴坦 75.2 18.3 替卡西林-克拉维酸 82.0 16.2 27.5 72.5 哌拉西林 84.0 11.6 14.7 79.3 哌拉西林-他唑巴坦 81.5 16.7 10.1 82.1 头孢哌酮-舒巴坦 51.5 20.1 11.9 77.6 亚胺培南 74.1 24.7 19.5 76.2 美罗培南 74.0 22.7 15.0 80.2 氨曲南 18.5 60.2 头孢他啶 78.2 20.9 11.0 86.1 头孢吡肟 81.3 17.1 13.4 77.2 庆大霉素 81.1 18.2 12.9 85.2 阿米卡星 79.2 19.6 8.6 90.6 环丙沙星 82.5 17.3 13.6 82.4 左氧氟沙星 79.5 18.0 16.0 78.5 7.3 90.0 磺胺甲噁唑-甲氧苄啶 60.8 27.6 6.4 92.7 米诺环素 28.9 39.9 0 96.6 -
[1] Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100-S23[S]. Wayne, PA: CLSI, 2013. [2] Wootton M, Howe RA, Walsh TR, et al. In vitro activity of 21 antimicrobials against vancomycin-resistant Staphylococcus aureus(VRSA) and heteroVRSA (hVRSA)[J]. J Antimicrob Chemother, 2002, 50:760-761. doi: 10.1093/jac/dkf184 [3] Hanaki H, Cui L, Ikeda-Dantsuji Y, et al. Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011[J]. J Infect Chemother, 2014, 20:527-534. doi: 10.1016/j.jiac.2014.06.012 [4] 胡付品, 朱德妹, 汪复, 等. 2012年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志, 2013, 13:321-330. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgkgrhlzz201305001 [5] Munoz-Price LS, Weinstein RA. Acinetobacter infection[J]. N Engl J Med, 2008, 358:1271-1281. doi: 10.1056/NEJMra070741 [6] 陈佰义, 何礼贤, 胡必杰, 等.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中国医药科学杂志, 2012, 2:3-8. http://www.cqvip.com/Main/Detail.aspx?id=41665523 [7] 杨菁菁, 艾效曼, 胡云建, 等.泛耐药铜绿假单胞菌对β内酰胺类抗生素的耐药机制研究[J].中国感染与化疗杂志, 2013, 13:14-18. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgkgrhlzz201301003
计量
- 文章访问数: 181
- HTML全文浏览量: 65
- PDF下载量: 5
- 被引次数: 0